NIH Global Health Funding News - Week of October 1, 2018

Top Fogarty News

Important news from Fogarty.

• Fogarty website improves security, users must update older web browsers
  As of Friday, October 12, 2018, computers using older browsers may not be able to access the website because many older browsers use outdated security standards. Users must enable TLS 1.1 or TLS 1.2 on their browser, or upgrade their browser to access Fogarty's website. Learn more.

Funding Opportunities

NIH funding opportunities focusing on global health and foreign collaboration.

• Prevention of HPV-related Cancers in HIV-infected individuals: United States-Latin American-Caribbean Clinical Trials Network: Partnership Centers (U54 Clinical Trial Required) (RFA-CA-18-018)
  Application due date: November 15, 2018
  • Related notice: [October 12, 2018] Pre-Application Webinar and Frequently Asked Questions (FAQ) for RFA-CA-18-018 Prevention of HPV-related Cancers in HIV-infected individuals: United States-Latin American-Caribbean Clinical Trials Network: Partnership Centers (U54) (NOT-CA-18-113)

NIH funding opportunities for which foreign organizations, foreign components of U.S. organizations and/or other foreign components may apply.

• Research on Chronic Overlapping Pain Conditions (R01 Clinical Trial Optional) (PA-18-937) and (R21 Clinical Trial Not Allowed) (PA-18-939)
  Application Receipt/Submission Date(s): Standard dates apply
• Discovery and Validation of Novel Targets for Safe and Effective Pain Treatment (R21 Clinical Trial Not Allowed) (RFA-NS-18-042) and (R01 Clinical Trial Not Allowed) (RFA-NS-18-043)
  Application Receipt Date(s): November 27, 2018; February 11, 2019; July 11,2019; November 12 , 2019
• Analytical and/or Clinical Validation of a Candidate Biomarker for Pain (R61/R33 Clinical Trial Optional) (RFA-NS-18-046)
  Application Receipt Date(s): November 27, 2018; March 7, 2019; November 25, 2019; March 12, 2020
• High-Priority Areas for Research Leveraging EHR and Large-Scale Data (R01 Clinical Trial Not Allowed) (PAR-18-929)
  Application Receipt/Submission Date(s): November 21, 2018
• Characterization of Mycobacterial Induced Immunity in HIV-infected and Uninfected Individuals (R21 Clinical Trial Not Allowed) (PAR-18-923)
  Application Receipt/Submission Date(s): January 14, 2019; January 14, 2020; January 14, 2021
• Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimers Dementia (R01 Clinical Trial Optional) (RFA-MH-19-510) and (R21 Clinical Trial Optional) (RFA-MH-19-511)
  Application Receipt Date(s): November 19, 2018 and March 19, 2019
• BRAIN Initiative Cell Census Network (BICCN):
  Scalable Technologies and Tools for Brain Cell Census (R01 Clinical Trial Not Allowed) (RFA-MH-19-148)
  Specialized Collaboratory on Human and Non-Human Primate Brain Cell Atlases (U01 Clinical Trial Not Allowed) (RFA-MH-19-149)
  Application Receipt Date(s): January 22, 2019 and January 24, 2020
• Development and Optimization of Tasks and Measures for Functional Domains of Behavior (R01 Clinical Trial Not Allowed) (PAR-18-930)
  Application Receipt/Submission Date(s): Standard dates apply
• Computational Approaches for Validating Dimensional Constructs of Relevance to Psychopathology (R01 Clinical Trial Optional) (RFA-MH-19-242)
  Application Receipt Date(s): January 3, 2019; November 20, 2019; November 20, 2020
• Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R21 Clinical Trial Optional) (PAR-18-941) and (R01 Clinical Trial Optional) (PAR-18-942)
  Application Receipt/Submission Date(s): November 26, 2018
• NIH Administrative Supplements to Recover Losses Due to Hurricanes Harvey, Irma, and Maria Under the Bipartisan Budget Act of 2018 Non-Construction (Admin Supp Clinical Trial Optional) (PA-18-936)
  Application Receipt/Submission Date(s): December 14, 2018

NIH funding opportunities for which United States small business concerns (SBCs) may collaborate with a foreign business entity.

• Innovative Technologies for HIV Behavioral and Social Science Research (R41/R42 Clinical Trial Optional) (PA-18-927) and (R43/R44 Clinical Trial Optional) (PA-18-928)
  Application Receipt/Submission Date(s): Standard dates apply
• Loyalty and Reward-Based Technologies to Increase Adherence to Substance Use Disorder Pharmacotherapies (R43/R44 - Clinical Trial Optional) (RFA-DA-19-014) and R41/R42 - Clinical Trial Optional) (RFA-DA-19-015)
  Application Receipt Date(s): December 14, 2018

Funding News

NIH funding news that may be relevant to global health researchers.

• Review of the Accuracy of Grants Information for Fiscal Year 2018 (NOT-OD-18-234)
• Notice Regarding 2018 Bayh-Dole Act Final Rule - Rights to Federally Funded Inventions and Licensing of Government Owned Inventions (NOT-OD-18-233)
• Request for Information: Optimizing the Design and Implementation of Emergency Medical Care Research Conducted Under Exception from Informed Consent Requirements for Emergency Research (EFIC) Requirements and Guidelines (NOT-HL-18-654)
• Request for Information (RFI) (NOT-AR-19-020) and Upcoming Webinar (NOT-AR-19-021) for the NIH Back Pain Consortium (BACPAC) Research Program
• Notice of Update on NIH Extension Policy for Early Stage Investigator Status (ESI) (NOT-OD-18-235)
• Announcement of the NCATS "Rare Diseases Are Not Rare!" Challenge (NOT-TR-19-002) with a total prize purse up to $5,000

Upcoming Deadlines

• Fulbright-Fogarty Fellows and Scholars in Public Health
  Application deadline: October 9, 2018

• Emerging Global Leader Award
  Application deadline: November 7, 2018

• Global Brain and Nervous System Disorders Research Across the Lifespan
  Application deadline: November 7, 2018

• Chronic, Noncommunicable Diseases and Disorders Research Training
  Application deadline: November 13, 2018

• International Research Scientist Development Award (IRSDA)
  Application deadline: March 7, 2019

• Planning for Noncommunicable Diseases and Disorders Research Training
  Application deadline: March 14, 2019